Quarterly report [Sections 13 or 15(d)]

Significant Accounting Policies (Tables)

v3.26.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Accounting Policies [Abstract]  
Schedule of Product Information
The Company categorizes revenue based on various factors, such as the nature of contracts, as follows:
Revenue Type Three Months Ended September 30, 2026 % of Total Three Months Ended September 30, 2025 % of Total
(dollars in thousands)
Capitated revenue $ 366,291  92.4  % $ 341,555  98.9  %
Other revenue:
Clinical fees & insurance revenue 755  0.2  872  0.3 
Care coordination / management fees 10,004  2.5  2,750  0.8 
Incentive fees and other revenue
19,294  4.9  76  0.0 
Total other revenue
30,053  7.6  3,698  1.1 
Total revenue $ 396,344  100.0  % $ 345,253  100.0  %
Revenue Type Nine Months Ended September 30, 2026 % of Total Nine Months Ended September 30, 2025 % of Total
(dollars in thousands)
Capitated revenue $ 1,112,188  95.1  % $ 1,062,796  98.9  %
Other revenue:
Clinical fees & insurance revenue 1,874  0.2  2,672  0.2 
Care coordination / management fees 25,280  2.2  8,112  0.8 
Incentive fees and other revenue
29,773  2.5  686  0.1 
Total other revenue
56,927  4.9  11,470  1.1 
Total revenue $ 1,169,115  100.0  % $ 1,074,266  100.0  %